Summary

Cancer Cachexia Market – Scope of Report
TMR’s report on the global cancer cachexia market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2023 to 2031. The report provides revenue of the global cancer cachexia market for the period 2017–2031, considering 2023 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global cancer cachexia market from 2023 to 2031.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the cancer cachexia market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global cancer cachexia market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global cancer cachexia market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global cancer cachexia market.

The report delves into the competitive landscape of the global cancer cachexia market. Key players operating in the global cancer cachexia market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global cancer cachexia market profiled in this report.

Key Questions Answered in Global cancer cachexia Market Report
• What is the sales/revenue generated by cancer cachexia across all regions during the forecast period?
• What are the opportunities in the global cancer cachexia market?
• What are the major drivers, restraints, opportunities, and threats in the market?
• Which regional market is set to expand at the fastest CAGR during the forecast period?
• Which segment is expected to generate the highest revenue globally in 2031?
• Which segment is projected to expand at the highest CAGR during the forecast period?
• What are the market positions of different companies operating in the global market?

Cancer Cachexia Market – Research Objectives and Research Approach
The comprehensive report on the global cancer cachexia market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global cancer cachexia market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2031 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global cancer cachexia market.

ページTOPに戻る

Table of Contents

1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Cancer Cachexia Market
4. Market Overview
4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution/Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Cancer Cachexia Market Analysis and Forecast, 2023–2031
5. Key Insights
5.1. Pipeline Analysis
5.2. Key Product/Brand Analysis
5.3. Key Mergers & Acquisitions
5.4. COVID-19 Pandemic Impact on Industry
6. Global Cancer Cachexia Market Analysis and Forecast, by Therapeutics
6.1. Introduction & Definition
6.2. Key Findings/Developments
6.3. Market Value Forecast, by Therapeutics, 2023–2031
6.3.1. Progestogens
6.3.2. Corticosteroids
6.3.3. Combination Therapies
6.3.4. Others
6.4. Market Attractiveness Analysis, by Therapeutics
7. Global Cancer Cachexia Market Analysis and Forecast, by Mechanism of Action
7.1. Introduction & Definition
7.2. Key Findings/Developments
7.3. Market Value Forecast, by Mechanism of Action, 2023–2031
7.3.1. Appetite Stimulators
7.3.2. Weight Loss Stabilizers
7.3.3. Others
7.4. Market Attractiveness Analysis, by Mechanism of Action
8. Global Cancer Cachexia Market Analysis and Forecast, by Distribution Channel
8.1. Introduction & Definition
8.2. Key Findings/Developments
8.3. Market Value Forecast, by Distribution Channel, 2023–2031
8.3.1. Hospital Stores
8.3.2. Retail Pharmacy Stores
8.3.3. Online Pharmacies
8.4. Market Attractiveness Analysis, by Mechanism of Action
9. Global Cancer Cachexia Market Analysis and Forecast, by Region
9.1. Key Findings
9.2. Market Value Forecast, by Region, 2023–2031
9.2.1. North America
9.2.2. Europe
9.2.3. Asia Pacific
9.2.4. Latin America
9.2.5. Middle East & Africa
9.3. Market Attractiveness Analysis, by Region
10. North America Cancer Cachexia Market Analysis and Forecast
10.1. Introduction
10.2. Key Findings
10.3. Market Value Forecast, by Therapeutics, 2023–2031
10.3.1. Progestogens
10.3.2. Corticosteroids
10.3.3. Combination Therapies
10.3.4. Others
10.4. Market Value Forecast, by Mechanism of Action, 2023–2031
10.4.1. Appetite Stimulators
10.4.2. Weight Loss Stabilizers
10.4.3. Others
10.5. Market Value Forecast, by Distribution Channel, 2023–2031
10.5.1. Hospital Stores
10.5.2. Retail Pharmacy Stores
10.5.3. Online Pharmacies
10.6. Market Value Forecast, by Country, 2023–2031
10.6.1. U.S.
10.6.2. Canada
10.7. Market Attractiveness Analysis
10.7.1. By Therapeutics
10.7.2. By Mechanism of Action
10.7.3. By Distribution Channel
10.7.4. By Country
11. Europe Cancer Cachexia Market Analysis and Forecast
11.1. Introduction
11.2. Key Findings
11.3. Market Value Forecast, by Therapeutics, 2023–2031
11.3.1. Progestogens
11.3.2. Corticosteroids
11.3.3. Combination Therapies
11.3.4. Others
11.4. Market Value Forecast, by Mechanism of Action, 2023–2031
11.4.1. Appetite Stimulators
11.4.2. Weight Loss Stabilizers
11.4.3. Others
11.5. Market Value Forecast, by Distribution Channel, 2023–2031
11.5.1. Hospital Stores
11.5.2. Retail Pharmacy Stores
11.5.3. Online Pharmacies
11.6. Market Value Forecast, by Country/Sub-region, 2023–2031
11.6.1. Germany
11.6.2. U.K.
11.6.3. France
11.6.4. Italy
11.6.5. Spain
11.6.6. Rest of Europe
11.7. Market Attractiveness Analysis
11.7.1. By Therapeutics
11.7.2. By Mechanism of Action
11.7.3. By Distribution Channel
11.7.4. By Country/Sub-region
12. Asia Pacific Cancer Cachexia Market Analysis and Forecast
12.1. Introduction
12.2. Key Findings
12.3. Market Value Forecast, by Therapeutics, 2023–2031
12.3.1. Progestogens
12.3.2. Corticosteroids
12.3.3. Combination Therapies
12.3.4. Others
12.4. Market Value Forecast, by Mechanism of Action, 2023–2031
12.4.1. Appetite Stimulators
12.4.2. Weight Loss Stabilizers
12.4.3. Others
12.5. Market Value Forecast, by Distribution Channel, 2023–2031
12.5.1. Hospital Stores
12.5.2. Retail Pharmacy Stores
12.5.3. Online Pharmacies
12.6. Market Value Forecast, by Country/Sub-region, 2023–2031
12.6.1. China
12.6.2. Japan
12.6.3. India
12.6.4. Australia & New Zealand
12.6.5. Rest of Asia Pacific
12.7. Market Attractiveness Analysis
12.7.1. By Therapeutics
12.7.2. By Mechanism of Action
12.7.3. By Distribution Channel
12.7.4. By Country/Sub-region
13. Latin America Cancer Cachexia Market Analysis and Forecast
13.1. Introduction
13.2. Key Findings
13.3. Market Value Forecast, by Therapeutics, 2023–2031
13.3.1. Progestogens
13.3.2. Corticosteroids
13.3.3. Combination Therapies
13.3.4. Others
13.4. Market Value Forecast, by Mechanism of Action, 2023–2031
13.4.1. Appetite Stimulators
13.4.2. Weight Loss Stabilizers
13.4.3. Others
13.5. Market Value Forecast, by Distribution Channel, 2023–2031
13.5.1. Hospital Stores
13.5.2. Retail Pharmacy Stores
13.5.3. Online Pharmacies
13.6. Market Value Forecast, by Country/Sub-region, 2023–2031
13.6.1. Brazil
13.6.2. Mexico
13.6.3. Rest of Latin America
13.7. Market Attractiveness Analysis
13.7.1. By Therapeutics
13.7.2. By Mechanism of Action
13.7.3. By Distribution Channel
13.7.4. By Country/Sub-region
14. Middle East & Africa Cancer Cachexia Market Analysis and Forecast
14.1. Introduction
14.2. Key Findings
14.3. Market Value Forecast, by Therapeutics, 2023–2031
14.3.1. Progestogens
14.3.2. Corticosteroids
14.3.3. Combination Therapies
14.3.4. Others
14.4. Market Value Forecast, by Mechanism of Action, 2023–2031
14.4.1. Appetite Stimulators
14.4.2. Weight Loss Stabilizers
14.4.3. Others
14.5. Market Value Forecast, by Distribution Channel, 2023–2031
14.5.1. Hospital Stores
14.5.2. Retail Pharmacy Stores
14.5.3. Online Pharmacies
14.6. Market Value Forecast, by Country/Sub-region, 2023–2031
14.6.1. GCC Countries
14.6.2. South Africa
14.6.3. Rest of Middle East & Africa
14.7. Market Attractiveness Analysis
14.7.1. By Therapeutics
14.7.2. By Mechanism of Action
14.7.3. By Distribution Channel
14.7.4. By Country/Sub-region
15. Competition Landscape
15.1. Market Player - Competitive Matrix (by Tier and Size of Companies)
15.2. Market Share Analysis, by Company (2022)
15.3. Company Profiles
15.3.1. Aeterna Zentaris, Inc.
15.3.1.1. Company Overview
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Financial Overview
15.3.1.5. Strategic Overview
15.3.2. Alder BioPharmaceuticals Inc.
15.3.2.1. Company Overview
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Financial Overview
15.3.2.5. Strategic Overview
15.3.3. Aphios Corporation
15.3.3.1. Company Overview
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Financial Overview
15.3.3.5. Strategic Overview
15.3.4. Eli Lilly and Company
15.3.4.1. Company Overview
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Financial Overview
15.3.4.5. Strategic Overview
15.3.5. GTx Inc.
15.3.5.1. Company Overview
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Financial Overview
15.3.5.5. Strategic Overview
15.3.6. Helsinn Group
15.3.6.1. Company Overview
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Financial Overview
15.3.6.5. Strategic Overview
15.3.7. Merck & Co. Inc.
15.3.7.1. Company Overview
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Financial Overview
15.3.7.5. Strategic Overview
15.3.8. Novartis AG
15.3.8.1. Company Overview
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Financial Overview
15.3.8.5. Strategic Overview
15.3.9. Bristol-Myers Squibb Company
15.3.9.1. Company Overview
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Financial Overview
15.3.9.5. Strategic Overview
15.3.10. XBiotech, Inc.
15.3.10.1. Company Overview
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Financial Overview
15.3.10.5. Strategic Overview